跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 68 条关于
“Selexis”
全部
68
临床试验
23
药物
17
机构
4
资讯
24
去年
KBI Biopharma Partners with Infinimmune to Advance Human-First Antibody Manufacturing for Atopic Dermatitis
去年
Veloxis Pharmaceuticals' Transplant Candidate VEL-101 Receives Official Name "Pegrizeprument"
去年
FDA's START Program Selects First Rare Disease Therapies for Accelerated Development
去年
Japan's National Cancer Center Launches Nationwide Clinical Trial Network with Paradigm Health
去年
SynaptixBio Selects Antisense Oligonucleotide Candidate for Rare Disease H-ABC Clinical Trials
上个月
Bristol Myers Squibb Selects Houston for $2.3 Billion Multi-Modal Manufacturing Campus
19天前
Roche Selects Singapore as Global Pilot Site for Precision Medicine in Cancer
上个月
PitchMI Selects 20 Michigan Startups to Compete for $2 Million in Funding
3年前
NCI Selects Two Assays for Vanguard Study on Multi-Cancer Detection Tests
9个月前
Invivyd Selects VBY329 as Potential Best-in-Class RSV Antibody for Pediatric Prevention
第 1 页,共 3 页
上一页
下一页